Drug Safety Settlement
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Maruti Suzuki gains on benefits from weaker yen
Reuters Market Eye - Maruti Suzuki(MRTI.NS) shares gain 0.75 percent on bets a steep depreciation in the yen will boost earnings by reducing the costs of imports from Japan.
Since hitting a low of 1.3838 on July 25, the INR/JPY has risen to the current level of 1.5314.
Traders also cite a report in The Economic Times that Maruti Suzuki is looking to enter the small pick-up truck segment.
A spokesman for Maruti Suzuki declines to comment on the company's future product plans when contacted by Reuters.
(Reporting by Manoj Dharra)
- Tweet this
- Share this
- Digg this